Intas Pharma

• 

  Aurobindo Pharma Gains On Buzz Of Big UK Acquisition

  Aurobindo Pharma shares gained over 1 per cent on Monday after a news report said that the Indian pharma company is a frontrunner to buy Teva Pharmaceutical's UK business, which had revenue of around $300 million last fiscal.

• 

  RPG Life Sells Gujarat Biotech Unit To Intas Pharma

  RPG Life Sciences has sold its Gujarat-based biotechnology unit to Intas Pharmaceuticals for Rs 25 crore to focus on core areas of business and improve long-term competitiveness in a rapidly changing market.

• Intas Pharma Expects US Approval for White Blood Cell Drug This Year

  Intas Pharmaceuticals Ltd could get approval this year to launch a version of Amgen Inc's white blood cell boosting Neulasta drug in the United States, chief financial officer Jayesh Shah said.

• Temasek Completes 10.16 Per Cent Stake Purchase in Intas Pharma

  Temasek Holding, investment arm of the Singapore government, has completed the acquisition of a 10.16 per cent stake in Intas Pharmaceuticals.